Core Viewpoint - UnitedHealth Group's stock experienced a decline of 5.18% on July 31, closing at $252.25 per share, with a trading volume of $2.758 billion and a total market capitalization of $228.826 billion [1] Financial Performance - As of June 30, 2025, UnitedHealth's total revenue is projected to reach $221.191 billion, reflecting a year-over-year growth of 11.35% [1] - The company's net income attributable to shareholders is expected to be $9.698 billion, showing a significant year-over-year increase of 245.49% [1] Analyst Ratings - On July 30, Oppenheimer downgraded UnitedHealth's target price to $325, while maintaining an "Outperform" rating [1] Company Overview - UnitedHealth Group is a diversified health and well-being company focused on improving health systems and promoting healthier lifestyles [1] - The company operates through two main platforms: UnitedHealthcare, which provides health insurance and benefits services, and Optum, which offers health services supported by information and technology [1]